Effect of muscle training on dyspnea in patients with chronic obstructive pulmonary disease

Abstract

Background: Rehabilitation training is beneficial for patients with chronic obstructive pulmonary disease (COPD). This study was aimed at evaluating the efficacy of muscle training on dyspnea. Methods: We used 5 common databases for conducting a meta-analysis included PubMed, the Cochrane Library, Science Direct, Web of Science and Clinical Trials.gov, and eligible randomized controlled trials (RCTs) were included. The main results of include studies were dyspnea of patients who had a clinical diagnosis of COPD measured using Borg score and Medical Research Council (MRC) or modified Medical Research Council (mMRC) scale as the criteria before and after intervention. The intervention measures included respiratory or expiratory muscles or upper limb (UL) or lower limb (LL) training. The mean differences (MD) with the 95% confidence interval (CI) were considered for summary statistics. We also assessed risk of bias using the Cochrane collaboration's tool, and the value of I 2 was applied to evaluate the heterogeneity of the trials. Results: Fourteen RCTs with 18 interventions (n = 860 participants) were included. Muscle training significantly improved dyspnea during exercise and in the daily life of patients with COPD (MD, 95% CI: −0.58, −0.84 to −0.32, P < .0001 and −0.44, −0.65 to −0.24, P < .0001, respectively). In the subgroup analyses, the trials that used respiratory muscle and UL trainings significantly improved dyspnea during exercise (MD, 95% CI: −0.72, −1.13 to −0.31, P = .0005 and −0.53, −0.91 to −0.15, P = .007, respectively). The studies also showed that the participants in the rehabilitation group, who received respiratory muscle and UL trainings, had a significant improvement of dyspnea in daily life (MD, 95% CI: −0.38, −0.67 to −0.09, P = .01 and −0.51, −0.80 to −0.22, P = .0007, respectively). Conclusion: There were some limitations that most of the subjects in this study were patients with moderate to severe COPD and were male, and the training period and duration were different. The analyses revealed that respiratory muscle and UL trainings can improve dyspnea in patients with COPD during exercise and in daily life.

Efficacy of Nasal High-Flow Oxygen Therapy in Chronic Obstructive Pulmonary Disease Patients in Long-Term Oxygen and Nocturnal Non-Invasive Ventilation during Exercise Training

“…We did not find an improvement in the 6MWD, but we did observe a change in the Borg scale for the perception of dyspnea and fatigue. This variation was statistically significant in both groups, and mostly in the experimental group, in line with studies by other authors [ 37 ]. In addition, we noted an improvement in the mMRC scale in the HFOT group.…”

Effects of respiratory muscle training on respiratory efficiency and health-related quality of life in sedentary women with fibromyalgia: a randomised controlled trial

“…Respiratory muscle training (RMT) is a therapy used in several pathologies to improve respiratory capacity. There is evidence about the positive effect of RMT in patients with chronic obstructive pulmonary disease (COPD) (6), amyotrophic lateral sclerosis (ALS) (7), and COVID-19 (8)(9)(10). In addition to the effects obtained on respiratory capacity, studies have found how patients experience improvements in QoL.…”

Effectiveness of precise and quantitative rapid pulmonary rehabilitation nursing program for elderly patients with lung cancer during the perioperative period: A randomized controlled trial

“…Exercise is one of the number of successful interventions improving the physical and psychological health of patients with different cancers (including lung cancer). 8 , 9 The perioperative management of patients with lung cancer includes cardiopulmonary rehabilitation; it can reduce symptoms and minimize cancer exacerbations. 8 , 9 Pulmonary rehabilitation can improve the exercise capacity and health-related quality of life of patients, and it reduces the presence of major symptoms like fatigue, dyspnea, depression, and others.…”